Thoracic Surgery

Lung Cancer

Questions discussed in this category

Is there any role for ctDNA testing after surgery or SBRT for Stage IB NSCLC to determine the need for adjuvant chemotherapy?

1 Answer available

What are the clear criteria for unresectability in locally advanced NSCLC patients, other than medical or anatomic?

Medical inoperability is clearly defined, anatomical resectability is also pretty much clear (invasion of trachea/carina/esophagus, etc). But what abo...

1 Answer available

Papers discussed in this category

JCO Precision Oncology, 2017 Sep 29

Circulating Tumor DNA in Non–Small-Cell Lung Cancer: A Primer for the Clinician

Nature, 2017-04-26

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.

Cancer discovery, 2017-12

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.

Lancet (London, England), 2009-08-01

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

J. Clin. Oncol., 2015 Nov 02

Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).

Thoracic Surgery

Lung Cancer

Questions discussed in this category

Papers discussed in this category

Related Topics in Thoracic Surgery